These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12679896)

  • 1. Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups.
    Bennett JE; Kauffman C; Walsh T; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Lee J; Pappas P; Powers J; Rex J; Verweij P; Viscoli C
    Clin Infect Dis; 2003 Apr; 36(Suppl 3):S123-7. PubMed ID: 12679896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.
    Bennett JE; Powers J; Walsh T; Viscoli C; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Kauffman C; Lee J; Pappas P; Rex J; Verweij P
    Clin Infect Dis; 2003 Apr; 36(Suppl 3):S117-22. PubMed ID: 12679895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection.
    Almyroudis NG; Kontoyiannis DP; Sepkowitz KA; DePauw BE; Walsh TJ; Segal BH
    Clin Infect Dis; 2006 Dec; 43(11):1449-55. PubMed ID: 17083020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.
    Bennett JE; Powers J; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Kauffman C; Lee J; Pappas P; Rex J; Verweij P; Viscoli C; Walsh T
    Clin Infect Dis; 2003 Apr; 36(Suppl 3):S113-6. PubMed ID: 12679894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triggers for driving treatment of at-risk patients with invasive fungal disease.
    Drgona L; Colita A; Klimko N; Rahav G; Ozcan MA; Donnelly JP
    J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii17-iii24. PubMed ID: 24155142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phaeohyphomycosis in a tertiary care cancer center.
    Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP
    Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy for invasive mycoses: evaluation of past clinical trial designs.
    Sobel JD
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S224-7. PubMed ID: 15546122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
    Erjavec Z; Kluin-Nelemans H; Verweij PE
    Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in clinical trials of prophylaxis of fungal infections.
    Powers JH
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S211-7. PubMed ID: 15546120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.
    Chamilos G; Kontoyiannis DP
    Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of new antifungal agents.
    Kauffman CA
    Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
    White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
    Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for polyenes in treating invasive mycoses?
    Cornely OA; Vehreschild JJ; Ullmann AJ
    Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The experience is CLEAR.
    Chandrasekar P
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():31-5. PubMed ID: 16707248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
    Sobel JD
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of efficacy trials of cytokines in combination with antifungal drugs.
    Kullberg BJ; Oude Lashof AM; Netea MG
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S218-23. PubMed ID: 15546121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.